Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

EPRX vs OCS: stock comparison and AI forecast

Eupraxia Pharmaceuticals Inc. (EPRX) and Oculis Holding Ag (OCS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

EPRX Eupraxia Pharmaceuticals Inc.

Market Cap
$435M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

OCS Oculis Holding Ag

Market Cap
$422M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

EPRX · OCS

Key facts

  • EPRX and OCS have similar market capitalizations ($435M and $422M).
  • OCS carries 0.20 times debt per unit of equity, against 0.07 times for EPRX.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricEPRXOCS
Market Cap$435M$422M
P/B Ratio5.30x–
EPS–$-6.06
Book Value/Share$1.25–
FCF/Share–$-3.47

Profitability & Margins

MetricEPRXOCS
ROE–-117.8%
ROA–-97.9%
ROIC–-99.5%
Tax Rate–0.1%

Financial Health

MetricEPRXOCS
Current Ratio15.12x5.96x
D/E Ratio0.07x0.20x
Financial Leverage1.05x1.20x
Working Capital$79M$230M

Cash Flow

MetricEPRXOCS
Operating Cash Flow–-$214M
Free Cash Flow–-$215M
Capital Spending–-$840K

Income Statement

MetricEPRXOCS
Operating Income–-$240M
Net Income–-$280M
R&D Expense–$170M

Dividend & Shareholder Information

MetricEPRXOCS
Shares Outstanding66M62M
FAQ

EPRX vs OCS: stock comparison and AI forecast

Which is bigger, EPRX or OCS?

EPRX and OCS have similar market capitalizations ($435M and $422M).

Which one does Intratio's AI model rank higher, EPRX or OCS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.